• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE GENUS; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE GENUS; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-1216
Device Problems Charging Problem (2892); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cognitive Changes (2551); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/07/2023
Event Type  Injury  
Event Description
It was reported that a deep brain stimulation (dbs) patient experienced cognitive issues and was admitted to the emergency room (er).The patient presented himself to the er with no remote control and dbs implantable pulse generator (ipg) was unreadable since the device was not charged per the physicians assessment.The patient underwent a procedure where the ipg was replaced with another of a different model four days later from being admitted.Physical analysis of the dbs ipg was not performed as it was retained by the facility.The patient did well post-operatively.
 
Event Description
It was reported that a deep brain stimulation (dbs) patient experienced cognitive issues and was admitted to the emergency room (er).The patient presented himself to the er with no remote control and dbs implantable pulse generator (ipg) was unreadable since the device was not charged per the physicians assessment.The patient underwent a procedure where the ipg was replaced with another of a different model four days later from being admitted.Physical analysis of the dbs ipg was not performed as it was retained by the facility.The patient did well post-operatively.Additional information received that the patient was non-compliant and didn't have the ability to recharge the device as a result the physician decided to replace the ipg with a non-rechargeable ipg.There were no malfunctions with the rechargeable ipg other than being depleted of charge per the physicians assessment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE GENUS
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
erik sherburne
25155 rye canyon loop
valencia, CA 91355
7632920920
MDR Report Key18481054
MDR Text Key332489694
Report Number3006630150-2023-08516
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729985044
UDI-Public08714729985044
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/07/2023
Device Model NumberDB-1216
Device Catalogue NumberDB-1216
Device Lot Number516310
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/11/2023
Initial Date FDA Received01/09/2024
Supplement Dates Manufacturer Received01/09/2024
Supplement Dates FDA Received01/24/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/07/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age66 YR
Patient SexMale
-
-